Cardiac fibrosis
WikiDoc Resources for Cardiac fibrosis |
Articles |
---|
Most recent articles on Cardiac fibrosis Most cited articles on Cardiac fibrosis |
Media |
Powerpoint slides on Cardiac fibrosis |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Cardiac fibrosis at Clinical Trials.gov Trial results on Cardiac fibrosis Clinical Trials on Cardiac fibrosis at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Cardiac fibrosis NICE Guidance on Cardiac fibrosis
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Cardiac fibrosis Discussion groups on Cardiac fibrosis Patient Handouts on Cardiac fibrosis Directions to Hospitals Treating Cardiac fibrosis Risk calculators and risk factors for Cardiac fibrosis
|
Healthcare Provider Resources |
Causes & Risk Factors for Cardiac fibrosis |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Cardiac fibrosis refers to an abnormal thickening of the heart valves due to inappropriate proliferation of cardiac fibroblasts.
Pathophysiology
These cells secrete collagen, and normally function to provide structural support for the heart. When over activated this process causes thickening and fibrosis, primarily on the tricuspid valve, but also occurring on the pulmonary valve, eventually leading to right-sided heart failure.
Certain diseases such as gastrointestinal carcinoid tumors, which release large amounts of serotonin into the blood, produce a characteristic pattern of mostly right sided cardiac fibrosis which can be identified at autopsy. This pathology has also been seen in certain african tribes who eat foods containing excess amounts of serotonin.
Some appetite suppressant drugs such as fenfluramine and chlorphentermine induce a similar pattern of cardiac fibrosis, by over-stimulating 5HT2B receptors on the cardiac fibroblast cells. These drugs consequently tended to cause increased risk of heart valve damage and subsequent heart failure, which eventually led to them being withdrawn from the market.
A compound found in red wine, resveratrol has been found to slow down the development of cardiac fibrosis.